|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 |
| (11) | Patento numeris | 2281037 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09730852.2 |
| Europos patento paraiškos padavimo data | 2009-04-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-02-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-11-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/002248 |
| Data | 2009-04-10 |
| (87) | Numeris | WO 2009/126307 |
| Data | 2009-10-15 |
| (30) | Numeris | Data | Šalis |
| 124021 P | 2008-04-11 | US |
| (72) |
MADISON, Edwin, L., US
THANOS, Christopher, US
|
| (73) |
Catalyst Biosciences, Inc.,
260 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF |
| FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF |